Clinical Toxicology · 2005 · 11 citations · 6 references
MedicinePharmacologyPharmacotherapyNeuropharmacologyPediatric PharmacotherapyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyChild PsychopharmacologyPediatric PsychopharmacologyPsychopharmacology In ChildrenAntipsychotic Medication UseAntipsychotic Side EffectsAripiprazole PharmacologyAtypical Antipsychotic TreatmentCns DepressionDopamine Partial AgonistsDrug Overdose In ChildrenUnintentional Overdose
Aripiprazole, 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl] butyloxy}-3,4-dihydro-2(1H)-quinolinone, is an atypical antipsychotic medication inaugurating the newest class of atypical antipsychotics: the partial dopamine agonists. It has a particularly long half-life of elimination and variable metabolism secondary to genetic polymorphism. We report an unintentional overdose of 195 mg (17.1 mg/kg) of aripiprazole in a 2.5 year-old child. This patient exhibited CNS depression not requiring respiratory support and without significant cardiovascular effects. CNS effects persisted for almost 2 weeks postingestion.
6
Atsushi Sugiyama, Yoshioki Satoh, Keitaro Hashimoto · Toxicology and Applied Pharmacology · 2001 · 55 citations